Literature DB >> 3034088

Viremia and immune response with sequential phlebovirus infections.

R B Tesh, S M Duboise.   

Abstract

Four groups of hamsters were infected sequentially with various combinations of Arumowot, Chagres, and Gabek Forest viruses. Following each infection, the survival, level of viremia, and immune response of the animals were monitored. All of the agents produced viremia in the hamsters, regardless of the order of their administration. The antibody response, as measured by plaque reduction neutralization test, was monotypic even after two consecutive phlebovirus infections. Arumowot and Chagres viruses produced nonfatal infections in adult hamsters, which were characterized by viremia of several days duration and subsequent antibody formation. In contrast, Gabek Forest virus produced a fulminating and rapidly fatal disease in phlebovirus nonimmune animals. In hamsters previously infected with Chagres and/or Arumowot viruses, Gabek Forest infection was less severe, indicating some degree of cross-protection. The degree of cross-protection was in part related to the sequence of previous phlebovirus infections. No evidence of immune enhancement or other immunopathologic events were observed in the animals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034088     DOI: 10.4269/ajtmh.1987.36.662

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  10 in total

Review 1.  Emergence of Toscana virus in the mediterranean area.

Authors:  Remi N Charrel; Laurence Bichaud; Xavier de Lamballerie
Journal:  World J Virol       Date:  2012-10-12

2.  High prevalence rates of antibody to three sandfly fever viruses (Sicilian, Naples, and Toscana) among Cypriots.

Authors:  R Eitrem; M Stylianou; B Niklasson
Journal:  Epidemiol Infect       Date:  1991-12       Impact factor: 2.451

3.  Potential animal reservoirs of Toscana virus and coinfections with Leishmania infantum in Turkey.

Authors:  Ender Dincer; Sepandar Gargari; Aykut Ozkul; Koray Ergunay
Journal:  Am J Trop Med Hyg       Date:  2015-02-23       Impact factor: 2.345

Review 4.  Emergence of Toscana virus in Europe.

Authors:  Rémi N Charrel; Pierre Gallian; José-María Navarro-Mari; Loredana Nicoletti; Anna Papa; Mária Paz Sánchez-Seco; Antonio Tenorio; Xavier de Lamballerie
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

5.  Experimental infection of ground squirrels (Spermophilus tridecemlineatus) with monkeypox virus.

Authors:  Robert B Tesh; Douglas M Watts; Ellena Sbrana; Marina Siirin; Vsevolod L Popov; Shu-Yuan Xiao
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

6.  Sand Fly-Associated Phlebovirus with Evidence of Neutralizing Antibodies in Humans, Kenya.

Authors:  David P Tchouassi; Marco Marklewitz; Edith Chepkorir; Florian Zirkel; Sheila B Agha; Caroline C Tigoi; Edith Koskei; Christian Drosten; Christian Borgemeister; Baldwyn Torto; Sandra Junglen; Rosemary Sang
Journal:  Emerg Infect Dis       Date:  2019-04       Impact factor: 6.883

Review 7.  Syrian Hamster as an Animal Model for the Study on Infectious Diseases.

Authors:  Jinxin Miao; Louisa S Chard; Zhimin Wang; Yaohe Wang
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

8.  Identification of Secreted Proteins Involved in Nonspecific dsRNA-Mediated Lutzomyia longipalpis LL5 Cell Antiviral Response.

Authors:  Andrea Martins-da-Silva; Erich Loza Telleria; Michel Batista; Fabricio Klerynton Marchini; Yara Maria Traub-Csekö; Antonio Jorge Tempone
Journal:  Viruses       Date:  2018-01-18       Impact factor: 5.048

9.  Rescue of infectious Arumowot virus from cloned cDNA: Posttranslational degradation of Arumowot virus NSs protein in human cells.

Authors:  Hoai J Hallam; Nandadeva Lokugamage; Tetsuro Ikegami
Journal:  PLoS Negl Trop Dis       Date:  2019-11-21

10.  Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells.

Authors:  P W Mason
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.